[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01GA01, streptomycin, Prucalopride may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01CG01, sulbactam, Prucalopride may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The metabolism of Prucalopride can be decreased when combined with Sulfamethoxazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02BA01, tamoxifen, The serum concentration of Prucalopride can be increased when it is combined with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Prucalopride can be decreased when combined with Teniposide.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Prucalopride may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S03AA02, tetracycline, The metabolism of Prucalopride can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R03DA07, theobromine, The risk or severity of adverse effects can be increased when Theobromine is combined with Prucalopride.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CA19, thiopental, The metabolism of Prucalopride can be decreased when combined with Thiopental.]
[G04BE06, moxisylyte, Prucalopride may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Prucalopride may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AX01, tilidine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tilidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01AA12, tobramycin, Prucalopride may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AX02, tramadol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tramadol.]
[N06AF04, tranylcypromine, The metabolism of Prucalopride can be decreased when combined with Tranylcypromine.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Prucalopride.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Prucalopride.]
[A03AB12, mepenzolate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Mepenzolate.]
[A16AX12, trientine, Prucalopride may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AA05, triflupromazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Triflupromazine.]
[N04AA01, trihexyphenidyl, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Trihexyphenidyl.]
[A03AA05, trimebutine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Trimebutine.]
[N03AC02, trimethadione, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Trimethadione.]
[C02BA01, trimethaphan, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03BB01, butylscopolamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Prucalopride can be decreased when combined with Troleandomycin.]
[S01FA06, tropicamide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tropicamide.]
[M03AA02, tubocurarine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tubocurarine.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EX04, vandetanib, The serum concentration of Prucalopride can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Prucalopride may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Prucalopride can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The serum concentration of Prucalopride can be increased when it is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Prucalopride can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Prucalopride can be increased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Prucalopride can be decreased when combined with Rilpivirine.]
[S01AA28, vancomycin, Prucalopride may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC24, ticagrelor, The serum concentration of Prucalopride can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Prucalopride can be increased when it is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Prucalopride can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Prucalopride can be decreased when combined with Vinblastine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AA03, warfarin, Prucalopride may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, The risk or severity of adverse effects can be increased when Xipamide is combined with Prucalopride.]
[J05AE02, indinavir, The metabolism of Prucalopride can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Prucalopride can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The metabolism of Prucalopride can be decreased when combined with Brentuximab vedotin.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Prucalopride can be increased when it is combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Prucalopride can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Prucalopride can be decreased when combined with Rabeprazole.]
[N05AE04, ziprasidone, The metabolism of Prucalopride can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The serum concentration of Drospirenone can be decreased when it is combined with Prucalopride.]
[V03AC02, deferiprone, Prucalopride may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Prucalopride may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tolterodine.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J02AC03, voriconazole, The metabolism of Prucalopride can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Atracurium.]
[S01FA01, atropine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Atropine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R07AX02, ivacaftor, The serum concentration of Prucalopride can be increased when it is combined with Ivacaftor.]
[B03XA04, peginesatide, Prucalopride may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Prucalopride.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BD12, mirabegron, The serum concentration of Prucalopride can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Prucalopride can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The serum concentration of Prucalopride can be increased when it is combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Prucalopride can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Prucalopride can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The risk or severity of adverse effects can be increased when Prucalopride is combined with Linaclotide.]
[L01EA04, bosutinib, The metabolism of Prucalopride can be decreased when combined with Bosutinib.]
[L01EX05, regorafenib, The serum concentration of Prucalopride can be increased when it is combined with Regorafenib.]
[N05CA04, barbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Barbital.]
[D02BA02, octinoxate, Prucalopride may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Prucalopride can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Rasagiline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA13, lercanidipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Lercanidipine.]
[R06AC06, thonzylamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Thonzylamine.]
[G04BD10, darifenacin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Prucalopride may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[H01CB05, pasireotide, The metabolism of Prucalopride can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Prucalopride can be increased when it is combined with Sildenafil.]
[V08CA11, gadofosveset, Prucalopride may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The serum concentration of Prucalopride can be increased when it is combined with Ponatinib.]
[A16AX08, teduglutide, Prucalopride may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Prucalopride can be increased when it is combined with Lomitapide.]
[C04AX11, bencyclane, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Bencyclane.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Prucalopride may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Prucalopride.]
[L04AX06, pomalidomide, Prucalopride may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A10BK02, canagliflozin, The serum concentration of Prucalopride can be increased when it is combined with Canagliflozin.]
[A06AX06, tegaserod, The risk or severity of adverse effects can be increased when Tegaserod is combined with Prucalopride.]
[L03AA12, ancestim, Prucalopride may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L04AA18, everolimus, The serum concentration of Prucalopride can be increased when it is combined with Everolimus.]
[N04AC01, benztropine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Prucalopride can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EE01, trametinib, Prucalopride may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Prucalopride may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, The serum concentration of Prucalopride can be increased when it is combined with Afatinib.]
[N06AX28, levomilnacipran, Prucalopride may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Bepridil.]
[A10BJ03, lixisenatide, Prucalopride may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Prucalopride may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Prucalopride may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AP05, simeprevir, The serum concentration of Prucalopride can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Prucalopride may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Prucalopride.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CH03, tasimelteon, Prucalopride may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Prucalopride can be increased when combined with Metreleptin.]
[L04AA32, apremilast, Apremilast may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02BG02, formestane, Prucalopride may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Prucalopride can be decreased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Prucalopride can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The serum concentration of Prucalopride can be increased when it is combined with Vorapaxar.]
[A03BA03, hyoscyamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hyoscyamine.]
[L01EM01, idelalisib, The metabolism of Prucalopride can be decreased when combined with Idelalisib.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[D11AA01, glycopyrronium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CM19, suvorexant, The serum concentration of Prucalopride can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Prucalopride can be increased when it is combined with Eliglustat.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AB04, phenolphthalein, The risk or severity of adverse effects can be increased when Phenolphthalein is combined with Prucalopride.]
[A06AH03, naloxegol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Naloxegol.]
[N04AA02, biperiden, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Biperiden.]
[A06AG02, bisacodyl, The risk or severity of adverse effects can be increased when Prucalopride is combined with Bisacodyl.]
[S03AA06, gentamicin, Prucalopride may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Prucalopride can be decreased when combined with Olaparib.]
[B01AF03, edoxaban, Prucalopride may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Prucalopride can be decreased when combined with Mirtazapine.]
[L01EF01, palbociclib, The serum concentration of Prucalopride can be increased when it is combined with Palbociclib.]
[J05AP07, daclatasvir, The serum concentration of Prucalopride can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Prucalopride can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AA09, difemerine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Difemerine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AP06, asunaprevir, The serum concentration of Prucalopride can be increased when it is combined with Asunaprevir.]
[A07DA06, eluxadoline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Eluxadoline.]
[A04AD14, rolapitant, The serum concentration of Prucalopride can be increased when it is combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Prucalopride can be increased when it is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The risk or severity of adverse effects can be increased when Prucalopride is combined with Magnesium peroxide.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01EC01, acetazolamide, The metabolism of Prucalopride can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, The metabolism of Prucalopride can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Prucalopride may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, The serum concentration of Prucalopride can be increased when it is combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Prucalopride.]
[L01XG03, ixazomib, Prucalopride may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Prucalopride may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The metabolism of Prucalopride can be decreased when combined with Elbasvir.]
[N05CA05, aprobarbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01XX52, venetoclax, The serum concentration of Prucalopride can be increased when it is combined with Venetoclax.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04BC01, bromocriptine, The metabolism of Prucalopride can be decreased when combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Prucalopride may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[R06AB01, brompheniramine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Brompheniramine.]
[C08CA01, amlodipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amlodipine.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Prucalopride.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07BC01, buprenorphine, The metabolism of Prucalopride can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The serum concentration of Prucalopride can be increased when it is combined with Arsenic trioxide.]
[M02AA03, clofezone, The metabolism of Prucalopride can be decreased when combined with Rabeprazole.]
[N02AF01, butorphanol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butorphanol.]
[S01GX07, azelastine, The metabolism of Prucalopride can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Prucalopride can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The risk or severity of adverse effects can be increased when Prucalopride is combined with Plecanatide.]
[L01EF02, ribociclib, The metabolism of Prucalopride can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AH05, naldemedine, Prucalopride may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Prucalopride may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[P01CA02, benznidazole, Prucalopride may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AE09, tipranavir, The serum concentration of Prucalopride can be increased when it is combined with Tipranavir.]
[N07XX13, valbenazine, Prucalopride may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L01EX10, midostaurin, The metabolism of Prucalopride can be decreased when combined with Midostaurin.]
[L04AC14, sarilumab, The metabolism of Prucalopride can be decreased when combined with Sarilumab.]
[J01MA23, delafloxacin, Prucalopride may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[D01AC10, bifonazole, The metabolism of Prucalopride can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01XX59, enasidenib, The serum concentration of Prucalopride can be increased when it is combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Prucalopride can be increased when it is combined with Neratinib.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Prucalopride can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04AA11, bornaprine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Bornaprine.]
[C03DA03, canrenone, The risk or severity of adverse effects can be increased when Canrenone is combined with Prucalopride.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Prucalopride can be decreased when combined with Acalabrutinib.]
[N05CA03, butobarbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butobarbital.]
[J05AX18, letermovir, The metabolism of Prucalopride can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The metabolism of Prucalopride can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Prucalopride.]
[R06AX18, acrivastine, Prucalopride may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, The metabolism of Prucalopride can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Prucalopride can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The risk or severity of adverse effects can be increased when Prucalopride is combined with Calcium polycarbophil.]
[A03AA03, camylofine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Camylofin.]
[C07AG02, carvedilol, The serum concentration of Prucalopride can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Prucalopride can be decreased when combined with Fostamatinib.]
[L04AA37, baricitinib, Prucalopride may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01GB14, plazomicin, Prucalopride may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[H01CC03, elagolix, The serum concentration of Prucalopride can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Prucalopride can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AX17, stiripentol, The serum concentration of Prucalopride can be increased when it is combined with Stiripentol.]
[L01EB07, dacomitinib, The serum concentration of Prucalopride can be increased when it is combined with Dacomitinib.]
[J01AA14, sarecycline, The serum concentration of Prucalopride can be increased when it is combined with Sarecycline.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[D08AE05, chloroxylenol, Prucalopride may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Chlorphenoxamine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R03BB08, revefenacin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Revefenacin.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EX13, gilteritinib, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Gilteritinib.]
[L01XJ03, glasdegib, The serum concentration of Prucalopride can be increased when it is combined with Glasdegib.]
[S01AA13, fusidic acid, The metabolism of Prucalopride can be decreased when combined with Fusidic acid.]
[B01AC23, cilostazol, Cilostazol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[P02BX04, triclabendazole, The metabolism of Prucalopride can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The serum concentration of Prucalopride can be increased when it is combined with Clarithromycin.]
[N06BA14, solriamfetol, Prucalopride may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Prucalopride can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AB05, castor oil, The risk or severity of adverse effects can be increased when Prucalopride is combined with Castor oil.]
[L01EM03, alpelisib, The metabolism of Prucalopride can be decreased when combined with Alpelisib.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03BX03, cicletanine, The risk or severity of adverse effects can be increased when Cicletanine is combined with Prucalopride.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EJ02, fedratinib, The serum concentration of Prucalopride can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Prucalopride can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Prucalopride can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The serum concentration of Prucalopride can be increased when it is combined with Istradefylline.]
[C03AA09, cyclothiazide, The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Prucalopride.]
[A06AB03, danthron, The risk or severity of adverse effects can be increased when Dantron is combined with Prucalopride.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G03DB05, demegestone, The serum concentration of Demegestone can be decreased when it is combined with Prucalopride.]
[N02CC08, lasmiditan, The serum concentration of Prucalopride can be increased when it is combined with Lasmiditan.]
[G03AC09, desogestrel, The serum concentration of Desogestrel can be decreased when it is combined with Prucalopride.]
[N03AX25, cenobamate, The serum concentration of Prucalopride can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M09AX08, golodirsen, Prucalopride may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Prucalopride may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dezocine.]
[J05AB16, remdesivir, The metabolism of Prucalopride can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Prucalopride can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Prucalopride can be decreased when combined with Amprenavir.]
[R02AA03, dichlorobenzyl alcohol, Prucalopride may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, The serum concentration of Dienogest can be decreased when it is combined with Prucalopride.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dihydrocodeine.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA16, clevidipine, The metabolism of Prucalopride can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Prucalopride can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Prucalopride can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Prucalopride can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The serum concentration of Prucalopride can be increased when it is combined with Tucatinib.]
[A03AA08, dihexyverine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Prucalopride can be increased when it is combined with Capmatinib.]
[G04BD09, trospium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EX19, ripretinib, The serum concentration of Prucalopride can be increased when it is combined with Ripretinib.]
[V08CA05, mangafodipir, Prucalopride may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA17, levamlodipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Levamlodipine.]
[L04AC19, satralizumab, The serum concentration of Prucalopride can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oliceridine.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EX23, pralsetinib, The serum concentration of Prucalopride can be increased when it is combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Prucalopride.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Chlorprothixene.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Prucalopride.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06BX18, vinpocetine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Vinpocetine.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B06AC06, berotralstat, The metabolism of Prucalopride can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Prucalopride can be increased when it is combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Prucalopride may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The serum concentration of Prucalopride can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Prucalopride can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Prucalopride can be increased when it is combined with Tepotinib.]
[L01EX25, umbralisib, The serum concentration of Prucalopride can be increased when it is combined with Umbralisib.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02BG07, flupirtine, Prucalopride may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A02BA01, cimetidine, The metabolism of Prucalopride can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07CA02, cinnarizine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Prucalopride can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Prucalopride can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Prucalopride may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Prucalopride can be decreased when combined with Citalopram.]
[C03DA05, finerenone, The risk or severity of adverse effects can be increased when Finerenone is combined with Prucalopride.]
[L04AA48, belumosudil, The serum concentration of Prucalopride can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Prucalopride can be decreased when combined with Fexinidazole.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AX25, St. John's wort extract, The metabolism of Prucalopride can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Prucalopride can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Prucalopride can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The serum concentration of Prucalopride can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Prucalopride can be increased when it is combined with Clofazimine.]
[B06AX04, mitapivat, The serum concentration of Prucalopride can be increased when it is combined with Mitapivat.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Prucalopride can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Clomipramine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01EB24, mavacamten, The serum concentration of Prucalopride can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03BA03, clopamide, The risk or severity of adverse effects can be increased when Clopamide is combined with Prucalopride.]
[N05AH02, clozapine, The metabolism of Prucalopride can be decreased when combined with Clozapine.]
[A10BK06, sotagliflozin, The serum concentration of Prucalopride can be increased when it is combined with Sotagliflozin.]
[J01GB12, arbekacin, Prucalopride may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Prucalopride can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cocaine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R05DA04, codeine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Codeine.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hexafluronium.]
[M04AC01, colchicine, The metabolism of Prucalopride can be decreased when combined with Colchicine.]
[A03AB10, hexocyclium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hexocyclium.]
[A03BB06, homatropine methylbromide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Homatropine methylbromide.]
[S01FA05, homatropine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Homatropine.]
[J01XB01, colistin, Prucalopride may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A04AA03, tropisetron, Prucalopride may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Prucalopride can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R06AX27, desloratadine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Desloratadine.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C05BB03, invert sugar, Prucalopride may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V08AB05, iopromide, Prucalopride may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Prucalopride may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Prucalopride may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J02AC02, itraconazole, The serum concentration of Prucalopride can be increased when it is combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05BA10, ketazolam, The metabolism of Prucalopride can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EA01, imatinib, The metabolism of Prucalopride can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Prucalopride can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Lacidipine.]
[A06AD12, lactitol, The risk or severity of adverse effects can be increased when Prucalopride is combined with Lactitol.]
[N03AX09, lamotrigine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Lamotrigine.]
[N07BC04, lofexidine, Lofexidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Prucalopride may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Prucalopride can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Mebeverine.]
[R06AD07, mequitazine, The metabolism of Prucalopride can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04AA03, methixene, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Metixene.]
[C04AX01, cyclandelate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cyclandelate.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Prucalopride.]
[N05AD03, metylperon, Prucalopride may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Prucalopride.]
[J01FA03, midecamycin, The metabolism of Prucalopride can be decreased when combined with Midecamycin.]
[S01FA04, cyclopentolate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cyclopentolate.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01XA18, cyclosporine, The serum concentration of Prucalopride can be increased when it is combined with Cyclosporine.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cyproheptadine.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03XA02, conivaptan, The serum concentration of Prucalopride can be increased when it is combined with Conivaptan.]
[G04BE09, vardenafil, The serum concentration of Prucalopride can be increased when it is combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Prucalopride can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Prucalopride can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, The metabolism of Prucalopride can be decreased when combined with Daunorubicin.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Prucalopride can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Prucalopride may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M03AC11, cisatracurium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cisatracurium.]
[R05DA06, normethadone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Normethadone.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AB10, escitalopram, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Escitalopram.]
[G04BD08, solifenacin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Solifenacin.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Prucalopride can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V04CH02, indigo carmine, Prucalopride may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Prucalopride can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Prucalopride can be decreased when combined with Dexamethasone.]
[N04AA08, dexetimide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Prucalopride can be decreased when combined with Oxybutynin.]
[A03AA01, oxyphencyclimine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oxyphencyclimine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R05DA09, dextromethorphan, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dextromethorphan.]
[N02AC01, dextromoramide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dextromoramide.]
[N06AB05, paroxetine, The metabolism of Prucalopride can be decreased when combined with Paroxetine.]
[N07BC06, heroin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AX15, peppermint oil, The metabolism of Prucalopride can be decreased when combined with Peppermint oil.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Prucalopride can be decreased when combined with Diazepam.]
[R05DA08, pholcodine, Prucalopride may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Diclofenamide is combined with Prucalopride.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AA07, dicyclomine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dicyclomine.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AX04, pinaverium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pinaverium.]
[A03AB14, pipenzolate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pipenzolate.]
[L01DC04, ixabepilone, The serum concentration of Prucalopride can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Prucalopride can be decreased when combined with Erlotinib.]
[C03CA03, piretanide, The risk or severity of adverse effects can be increased when Piretanide is combined with Prucalopride.]
[L02AA01, diethylstilbestrol, The metabolism of Prucalopride can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Prucalopride can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, Prucalopride may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[A03AB11, poldine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01AA05, digoxin, Prucalopride may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02CA01, dihydroergotamine, The metabolism of Prucalopride can be decreased when combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hydromorphone.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Prucalopride can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Prucalopride may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Prucalopride can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Prucalopride may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R06AB03, dimethindene, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Prucalopride can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C05CA03, diosmin, The serum concentration of Prucalopride can be increased when it is combined with Diosmin.]
[R06AA02, diphenhydramine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Diphenhydramine.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Diphenoxylate.]
[S01AX06, resorcinol, Prucalopride may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Disopyramide.]
[S02AA12, rifamycin SV, The serum concentration of Prucalopride can be increased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Prucalopride can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Levocetirizine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EX01, sunitinib, The metabolism of Prucalopride can be decreased when combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Prucalopride can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The risk or severity of adverse effects can be increased when Tolvaptan is combined with Prucalopride.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01EB18, ranolazine, The serum concentration of Prucalopride can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AA16, dothiepin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Dosulepin.]
[N06AA12, doxepin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Doxepin.]
[A06AB06, sennosides, USP, The risk or severity of adverse effects can be increased when Prucalopride is combined with Sennosides.]
[L01DB01, doxorubicin, The metabolism of Prucalopride can be decreased when combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R06AA09, doxylamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Doxylamine.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C10AA01, simvastatin, The serum concentration of Prucalopride can be increased when it is combined with Simvastatin.]
[V03AG05, sodium phosphate, The risk or severity of adverse effects can be increased when Prucalopride is combined with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, Prucalopride may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BD05, terodiline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Terodiline.]
[G04BD01, emepronium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Emepronium.]
[G01AF08, tioconazole, The metabolism of Prucalopride can be decreased when combined with Tioconazole.]
[N05BA23, tofisopam, The metabolism of Prucalopride can be decreased when combined with Tofisopam.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AG03, toloxatone, Prucalopride may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02BA02, toremifene, The serum concentration of Prucalopride can be increased when it is combined with Toremifene.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Prucalopride.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AB08, tridihexethyl, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tridihexethyl.]
[N04AA12, tropatepine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tropatepine.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01GA03, xylometazoline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Xylometazoline.]
[C08CA12, mepirodipine, The metabolism of Prucalopride can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Prucalopride can be decreased when combined with Epinephrine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AX15, zonisamide, The serum concentration of Prucalopride can be increased when it is combined with Zonisamide.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02CA02, ergotamine, The metabolism of Prucalopride can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Prucalopride may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The serum concentration of Erythromycin can be increased when it is combined with Prucalopride.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G03CA03, estradiol, The serum concentration of Estradiol can be decreased when it is combined with Prucalopride.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Prucalopride can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Prucalopride can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Prucalopride can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The serum concentration of Ethinylestradiol can be decreased when it is combined with Prucalopride.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04AA05, profenamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Profenamine.]
[N03AD01, ethosuximide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Ethosuximide.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Ethylmorphine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Prucalopride can be decreased when combined with Etoposide.]
[L04AD02, tacrolimus, The serum concentration of Prucalopride can be increased when it is combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Prucalopride can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Prucalopride can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Prucalopride can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Prucalopride may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Prucalopride may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA02, felodipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Felodipine.]
[C08EA01, fendiline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fendiline.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R03CC04, fenoterol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fenoterol.]
[N02AB03, fentanyl, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fentanyl.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BD02, flavoxate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Flavoxate.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J02AC01, fluconazole, The serum concentration of Prucalopride can be increased when it is combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N07CA03, flunarizine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Flunarizine.]
[V03AZ01, ethanol, The metabolism of Prucalopride can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AB03, fluoxetine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fluoxetine.]
[N05AF01, flupenthixol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Flupentixol.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AG01, fluspirilene, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fluspirilene.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01BC03, tegafur, Prucalopride may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[M03AA01, alcuronium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Alcuronium.]
[J05AE10, darunavir, The metabolism of Prucalopride can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Prucalopride.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M03AC02, gallamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Gallamine.]
[C08DA02, gallopamil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Gallopamil.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Prucalopride can be decreased when combined with Dasatinib.]
[N04BC06, cabergoline, The metabolism of Prucalopride can be decreased when combined with Cabergoline.]
[N03AD03, methsuximide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Methsuximide.]
[G03XA02, gestrinone, The serum concentration of Gestrinone can be decreased when it is combined with Prucalopride.]
[N01AH02, alfentanil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Alfentanil.]
[L01EH01, lapatinib, The serum concentration of Prucalopride can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Prucalopride can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AX01, glycerin, The risk or severity of adverse effects can be increased when Prucalopride is combined with Glycerin.]
[L01EX02, sorafenib, The serum concentration of Prucalopride can be increased when it is combined with Sorafenib.]
[M01CB04, aurothioglucose, Prucalopride may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Prucalopride.]
[N05AH04, quetiapine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Quetiapine.]
[N06BX13, idebenone, Prucalopride may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09CA01, losartan, The metabolism of Prucalopride can be decreased when combined with Losartan.]
[B05CB03, magnesium citrate, The risk or severity of adverse effects can be increased when Prucalopride is combined with Magnesium citrate.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The risk or severity of adverse effects can be increased when Prucalopride is combined with Sodium fluorophosphate.]
[N05CA16, hexobarbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hexobarbital.]
[C08CA10, nilvadipine, The metabolism of Prucalopride can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nimesulide.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Prucalopride can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Prucalopride.]
[R05DA03, hydrocodone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hydrocodone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Prucalopride.]
[B05XA17, potassium acetate, Prucalopride may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Prucalopride.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BD06, propiverine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Propiverine.]
[B05AA07, hetastarch, Prucalopride may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B05XA08, sodium acetate, Prucalopride may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[A06AD21, sodium tartrate, The risk or severity of adverse effects can be increased when Prucalopride is combined with Sodium tartrate.]
[L01AA06, ifosfamide, The metabolism of Prucalopride can be decreased when combined with Ifosfamide.]
[N01AH03, sufentanil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Sufentanil.]
[N06AA02, imipramine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Imipramine.]
[R01AD07, tixocortol, Prucalopride may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The metabolism of Prucalopride can be decreased when combined with Topotecan.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Prucalopride.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A11HA07, inositol, Prucalopride may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Prucalopride can be decreased when combined with Milnacipran.]
[A03AA30, piperidolate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Piperidolate.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R06AE01, buclizine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Buclizine.]
[C10AA06, cerivastatin, The metabolism of Prucalopride can be decreased when combined with Cerivastatin.]
[C03BA02, quinethazone, The risk or severity of adverse effects can be increased when Quinethazone is combined with Prucalopride.]
[V03AB01, ipecac, Prucalopride may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N01AB06, isoflurane, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Isoflurane.]
[J04AC01, isoniazid, The metabolism of Prucalopride can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Prucalopride may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01AA24, kanamycin, Prucalopride may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J02AB02, ketoconazole, The serum concentration of Prucalopride can be increased when it is combined with Ketoconazole.]
[H02CA04, levoketoconazole, The serum concentration of Prucalopride can be increased when it is combined with Levoketoconazole.]
[N05AH03, olanzapine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AD11, lactulose, The risk or severity of adverse effects can be increased when Lactulose is combined with Prucalopride.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Prucalopride.]
[G03AD01, levonorgestrel, The serum concentration of Levonorgestrel can be decreased when it is combined with Prucalopride.]
[C08EX01, lidoflazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Lidoflazine.]
[S01AA21, amikacin, Prucalopride may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Prucalopride.]
[A07DA03, loperamide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Prucalopride can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of Prucalopride can be increased when it is combined with Loxapine.]
[G03DC03, lynestrenol, The serum concentration of Lynestrenol can be decreased when it is combined with Prucalopride.]
[L01EG01, temsirolimus, The serum concentration of Prucalopride can be increased when it is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Prucalopride may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Prucalopride may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[A12CC10, magnesium oxide, The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Prucalopride.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, Prucalopride may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Prucalopride can be increased when it is combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Prucalopride.]
[N06AA21, maprotiline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Maprotiline.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R06AE05, meclizine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Meclizine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AB07, cascara sagrada, The risk or severity of adverse effects can be increased when Prucalopride is combined with Frangula purshiana bark.]
[P01BC02, mefloquine, The serum concentration of Prucalopride can be increased when it is combined with Mefloquine.]
[C03BA05, mefruside, The risk or severity of adverse effects can be increased when Mefruside is combined with Prucalopride.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AB02, meperidine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Meperidine.]
[N03AA01, mephobarbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Methylphenobarbital.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AX05, meptazinol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Meptazinol.]
[G04BX16, tiopronin, Prucalopride may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, The risk or severity of adverse effects can be increased when Mersalyl is combined with Prucalopride.]
[N05AX13, paliperidone, The serum concentration of Prucalopride can be increased when it is combined with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[H01CB03, lanreotide, The metabolism of Prucalopride can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Prucalopride can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AB07, methantheline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Methantheline.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AA30, metharbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Metharbital.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Prucalopride.]
[H03BB02, methimazole, The metabolism of Prucalopride can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Prucalopride may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02BG08, ziconotide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Ziconotide.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Prucalopride.]
[A06AC06, methylcellulose, The risk or severity of adverse effects can be increased when Prucalopride is combined with Methylcellulose.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Prucalopride can be increased when it is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Prucalopride can be decreased when combined with Methylergometrine.]
[G03EK01, methyltestosterone, Prucalopride may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Metoclopramide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Prucalopride.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Prucalopride can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Prucalopride can be decreased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Prucalopride can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CD08, midazolam, The metabolism of Prucalopride can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Prucalopride can be increased when it is combined with Mifepristone.]
[A06AA01, mineral oil, The risk or severity of adverse effects can be increased when Prucalopride is combined with Mineral oil.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01XX23, mitotane, The metabolism of Prucalopride can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Prucalopride can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The serum concentration of Prucalopride can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amitriptyline.]
[N02AA01, morphine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Morphine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Prucalopride may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Prucalopride may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Prucalopride can be decreased when combined with Pazopanib.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Vecuronium.]
[N05CA02, amobarbital, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amobarbital.]
[G03XC01, raloxifene, The metabolism of Prucalopride can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Prucalopride can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AF02, nalbuphine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Prucalopride can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Prucalopride can be decreased when combined with Docetaxel.]
[S03AA01, neomycin, Prucalopride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Remifentanil.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L03AX16, plerixafor, Prucalopride may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Prucalopride may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Prucalopride can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA04, nicardipine, The metabolism of Prucalopride can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CA06, nimodipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nimodipine.]
[C08CA07, nisoldipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nisoldipine.]
[C08CA08, nitrendipine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nitrendipine.]
[R07AX01, nitric oxide, The metabolism of Prucalopride can be decreased when combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G03DC02, norethindrone, The serum concentration of Norethisterone can be decreased when it is combined with Prucalopride.]
[S01AE02, norfloxacin, The metabolism of Prucalopride can be decreased when combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Norgestrienone can be decreased when it is combined with Prucalopride.]
[N06AA10, nortriptyline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nortriptyline.]
[R05DA07, noscapine, The metabolism of Prucalopride can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, The serum concentration of Prucalopride can be increased when it is combined with Sapropterin.]
[G02CA02, nylidrin, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nylidrin.]
[H01CB02, octreotide, The metabolism of Prucalopride can be decreased when combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Prucalopride can be decreased when combined with Oleandomycin.]
[A02BC01, omeprazole, The metabolism of Prucalopride can be decreased when combined with Omeprazole.]
[N02AA02, opium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Opium.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02AA05, oxycodone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oxycodone.]
[A14AA05, oxymetholone, The metabolism of Prucalopride can be decreased when combined with Oxymetholone.]
[N02AA11, oxymorphone, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oxymorphone.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A03AB03, oxyphenonium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Oxyphenonium.]
[N02AX06, tapentadol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Tapentadol.]
[M03AC01, pancuronium, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pancuronium.]
[J04AB30, capreomycin, Prucalopride may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03DB06, chlormadinone, The serum concentration of Chlormadinone can be decreased when it is combined with Prucalopride.]
[H02AB05, paramethasone, The metabolism of Prucalopride can be decreased when combined with Paramethasone.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G04BD11, fesoterodine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Fesoterodine.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AG03, penfluridol, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Penfluridol.]
[J01CE09, penicillin G procaine, Prucalopride may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N02AD01, pentazocine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, The metabolism of Prucalopride can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Prucalopride may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08EX02, perhexiline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Perhexiline.]
[N02AD02, phenazocine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N06AF03, phenelzine, The metabolism of Prucalopride can be decreased when combined with Phenelzine.]
[N03AA02, phenobarbital, The metabolism of Prucalopride can be increased when combined with Phenobarbital.]
[A06AB01, oxyphenisatin, The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Prucalopride.]
[N01AH04, phenoperidine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Phenoperidine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N03AB02, phenytoin, The metabolism of Prucalopride can be increased when combined with Phenytoin.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Prucalopride can be decreased when combined with Bicalutamide.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C08CX01, mibefradil, The serum concentration of Prucalopride can be increased when it is combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Prucalopride can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Prucalopride can be decreased when combined with Pimozide.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J05AE01, saquinavir, The serum concentration of Prucalopride can be increased when it is combined with Saquinavir.]
[N06BX03, piracetam, Prucalopride may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[A02BX03, pirenzepine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pirenzepine.]
[N02AC03, pirinitramide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02CX01, pizotyline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Pizotifen.]
[J05AG02, delavirdine, The metabolism of Prucalopride can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Prucalopride can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A06AD15, polyethylene glycols, The risk or severity of adverse effects can be increased when Prucalopride is combined with Polyethylene glycol.]
[C03AA05, polythiazide, The risk or severity of adverse effects can be increased when Polythiazide is combined with Prucalopride.]
[J05AE03, ritonavir, The serum concentration of Prucalopride can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01DX02, prenylamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Prenylamine.]
[P01BA03, primaquine, The metabolism of Prucalopride can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Prucalopride can be increased when combined with Primidone.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01BA02, procainamide, Prucalopride may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Procaine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N04AA04, procyclidine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Procyclidine.]
[N05AA03, promazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Promethazine.]
[C01BC03, propafenone, The serum concentration of Prucalopride can be increased when it is combined with Propafenone.]
[A03AB05, propantheline, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Propantheline.]
[N05CM06, propiomazine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Propiomazine.]
[N01AX10, propofol, The metabolism of Prucalopride can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Prucalopride can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[N05AX12, aripiprazole, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Aripiprazole.]
[N07XX07, dalfampridine, Prucalopride may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[A03AB15, diphemanil, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Diphemanil.]
[A03AB09, isopropamide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Isopropamide.]
[S01FA03, methscopolamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Methscopolamine.]
[N05CA07, talbutal, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Talbutal.]
[P02CC01, pyrantel, Prucalopride may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01BA01, quinidine, The serum concentration of Prucalopride can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The serum concentration of Prucalopride can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C02AA02, reserpine, The serum concentration of Prucalopride can be increased when it is combined with Reserpine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Prucalopride can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Prucalopride can be decreased when combined with Roxithromycin.]
[C05CA01, rutin, The metabolism of Prucalopride can be decreased when combined with Rutin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[S01FA02, scopolamine, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Scopolamine.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[J01GB08, sisomicin, Prucalopride may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Prucalopride may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[H01CB01, somatostatin, The metabolism of Prucalopride can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Prucalopride.]
[N02BA03, choline salicylate, Prucalopride may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Prucalopride may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Prucalopride may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Prucalopride may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Prucalopride can be decreased when combined with Valproic acid.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[R03BB01, ipratropium bromide, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Ipratropium.]
